SANJIVINPharmaceuticals
Sanjivani Paranteral Ltd — PE Ratio & Valuation Analysis
₹132.75
-4.83%
Current P/E32.04xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E73.6x56.5% below avg
⚠️
0.8% Premium to Industry
SANJIVIN P/E 32.04x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹5.28 | ₹388 | 73.6x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Sanjivani Paranteral Ltd Valuation
Sanjivani Paranteral Ltd (SANJIVIN) currently trades at 32.04x earnings. The Pharmaceuticals sector average PE is 31.77x. SANJIVIN commands a premium, reflecting high growth expectations. Historically, SANJIVIN has traded at an average PE of 73.6x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
24.58%
Dividend Yield
0.26%
More on Sanjivani Paranteral Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.